Ubs Group Ag Abiomed Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$242.49 - $301.46 $2.95 Million - $3.67 Million
-12,164 Reduced 25.76%
35,053 $8.61 Million
Q2 2022

Aug 10, 2022
BUY
$224.73 - $338.64 $2.57 Million - $3.87 Million
11,432 Added 31.95%
47,217 $11.7 Million
Q1 2022

May 16, 2022
SELL
$277.25 - $366.29 $355,989 - $470,316
-1,284 Reduced 3.46%
35,785 $11.9 Million
Q4 2021

Feb 14, 2022
BUY
$300.63 - $371.35 $2.59 Million - $3.19 Million
8,599 Added 30.2%
37,069 $13.3 Million
Q3 2021

Nov 15, 2021
SELL
$310.19 - $376.2 $2.17 Million - $2.63 Million
-6,989 Reduced 19.71%
28,470 $9.27 Million
Q2 2021

Aug 13, 2021
SELL
$262.71 - $351.17 $1.06 Million - $1.42 Million
-4,039 Reduced 10.23%
35,459 $11.1 Million
Q1 2021

May 12, 2021
BUY
$285.92 - $355.13 $2.69 Million - $3.34 Million
9,402 Added 31.24%
39,498 $12.6 Million
Q4 2020

Feb 11, 2021
SELL
$251.88 - $324.2 $5 Million - $6.43 Million
-19,835 Reduced 39.72%
30,096 $9.76 Million
Q3 2020

Nov 12, 2020
BUY
$255.22 - $317.0 $3.01 Million - $3.74 Million
11,806 Added 30.97%
49,931 $13.8 Million
Q2 2020

Jul 31, 2020
BUY
$141.4 - $257.09 $2.44 Million - $4.44 Million
17,274 Added 82.84%
38,125 $9.21 Million
Q1 2020

May 01, 2020
BUY
$130.51 - $196.01 $1.21 Million - $1.82 Million
9,297 Added 80.47%
20,851 $3.03 Million
Q4 2019

Feb 14, 2020
SELL
$159.31 - $223.54 $2.04 Million - $2.87 Million
-12,834 Reduced 52.62%
11,554 $1.97 Million
Q3 2019

Nov 14, 2019
SELL
$175.89 - $279.23 $2.66 Million - $4.22 Million
-15,114 Reduced 38.26%
24,388 $4.34 Million
Q2 2019

Aug 14, 2019
SELL
$250.96 - $284.94 $5.23 Million - $5.94 Million
-20,832 Reduced 34.53%
39,502 $10.3 Million
Q1 2019

May 14, 2019
BUY
$276.39 - $362.25 $2.62 Million - $3.44 Million
9,491 Added 18.67%
60,334 $17.2 Million
Q4 2018

Feb 14, 2019
SELL
$281.08 - $444.25 $10.4 Million - $16.4 Million
-36,882 Reduced 42.04%
50,843 $16.5 Million
Q3 2018

Nov 14, 2018
BUY
$354.53 - $449.75 $2.04 Million - $2.58 Million
5,741 Added 7.0%
87,725 $39.5 Million
Q2 2018

Aug 14, 2018
BUY
$278.07 - $446.21 $4.23 Million - $6.79 Million
15,213 Added 22.78%
81,984 $33.5 Million
Q1 2018

May 15, 2018
BUY
$192.49 - $295.85 $1.3 Million - $1.99 Million
6,740 Added 11.23%
66,771 $19.4 Million
Q4 2017

Feb 14, 2018
SELL
$168.78 - $199.74 $101,774 - $120,443
-603 Reduced 0.99%
60,031 $11.3 Million
Q3 2017

Nov 14, 2017
BUY
$145.39 - $168.6 $2.37 Million - $2.75 Million
16,323 Added 36.84%
60,634 $10.2 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,343 Added 5.58%
44,311 $6.35 Million
Q1 2017

Nov 14, 2017
BUY
N/A
41,968
41,968 $5.25 Million

Others Institutions Holding ABMD

# of Institutions
12
Shares Held
137K
Call Options Held
0
Put Options Held
0
View Full List

About ABIOMED INC

ABMD Quotes by TradingView
  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email